JOURNAL TOOLS Get New Content Alerts Get RSS feed Save to My Profile Get Sample Copy Recommend to Your Librarian JOURNAL MENU Journal Home FIND ISSUES Current Issue All Issues FIND ARTICLES Early View Editors' Choice Most Accessed Most Cited GET ACCESS Subscribe / Renew FOR CONTRIBUTORS OnlineOpen Author Guidelines Submit an Article ABOUT THIS JOURNAL News Overview Editorial Board Permissions Advertise Contact SPECIAL FEATURES Virtual Issue Collection Wiley's Pathology Collection Wiley Job Network Follow Cytopathology on Twitter Jobs OnlineOpen Option Available You have full text access to this content Which women default from follow-up cervical cytology tests? A cohort study within the TOMBOLA trial L. Sharp1, S. Cotton2, A. Thornton3, N. Gray4, D. Whynes5, L. Smart6, N. Waugh3, I. Duncan7, M. Cruickshank8, J. Little9 andon behalf of the TOMBOLA Group† Article first published online: 2 MAR 2011 DOI: 10.1111/j.1365-2303.2011.00848.x © 2011 Blackwell Publishing Ltd Issue Cytopathology Cytopathology Volume 23, Issue 3, pages 150–160, June 2012 Additional Information(Show All) How to Cite Author Information Publication History Author Information 1 National Cancer Registry Ireland, Cork, Ireland 2 Health Service Research Unit, University of Aberdeen, Aberdeen, UK 3 Department of Public Health, University of Aberdeen, Aberdeen, UK 4 Centre for Academic Primary Care, University of Aberdeen, Aberdeen, UK 5 School of Economics, University of Nottingham, Nottingham, UK 6 Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, UK 7 Department of Obstetrics & Gynaecology, Ninewells Hospital, Dundee, UK 8 Department of Obstetrics & Gynaecology, University of Aberdeen, Aberdeen, UK 9 Department of Epidemiology & Community Medicine, University of Ottawa, Ottawa, Canada † Group members are listed at the end of the paper. *L. Sharp, National Cancer Registry Ireland, Building 6800, Kinsale Road, Cork, Ireland Tel.: +353-21-4318014; E-mail: firstname.lastname@example.org SEARCH Search Scope Objective: To identify factors associated with default from follow-up cervical cytology tests. Methods: A cohort study was conducted involving 2166 women, aged 20–59, with recent low-grade cervical cytology taken within the NHS Cervical Screening Programmes in Scotland and England, and managed by 6-monthly cytology in primary care. For the first (6-month) and second (12-month) surveillance cytology tests separately, women were categorized as ‘on-time attendees’ (attended ≤6 months of test being due), ‘late attendees’ (attended greater than 6 months after test was due) or ‘non-attendees’ (failed to attend). Multivariate odds ratios (ORs) were computed for factors associated with late and non-attendance. Results: For the first surveillance test, risk of non-attendance was significantly higher in younger women, those without post-secondary education, and non-users of prescribed contraception. Factors significantly associated with late attendance for the first test were the same as for non-attendance, plus current smoking and having children. The most important predictor of non-attendance for the second surveillance test was late attendance for the first test (OR = 9.65; 95% CI, 6.60–16.62). Non-attendance for the second test was also significantly higher among women who were younger, smokers and had negative cytology on the first surveillance test. Late attendance for the second surveillance test was higher in women who were younger, smokers, had children and attended late for the first test. Conclusions: Women at highest risk of default from follow-up cytology tend to be young, smoke, lack post-secondary education, and have defaulted from a previous surveillance appointment. Tackling default will require development of targeted strategies to encourage attendance and research to better understand the reasons underpinning default.
|Number of pages||11|
|Journal||Cytopathology : Official Journal of the British Society for Clinical Cytology|
|Publication status||Published - Jun 2012|